Skip to main content
. 2012 Apr 25;27(5):476–483. doi: 10.3346/jkms.2012.27.5.476

Table 1.

Baseline and clinical characteristics and duration of study therapy in randomized and microbiologically evaluable patients by treatment group

graphic file with name jkms-27-476-i001.jpg

*The duration of symptoms prior to study entry; In randomized patients: for ertapenem, n = 132; for ceftriaxone, n = 135. SD, standard deviation; APN, acute pyelonephritis; cUTI, complicated urinary tract infection.